{"id":210372,"date":"2026-08-18T13:50:46","date_gmt":"2026-08-18T08:20:46","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=210372"},"modified":"2026-08-18T13:50:46","modified_gmt":"2026-08-18T08:20:46","slug":"why-manipal-health-enterpri-l-share-price-52-week-high-2026-08-18-2","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-manipal-health-enterpri-l-share-price-52-week-high-2026-08-18-2\/","title":{"rendered":"MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Share Price Hits Fresh 52-Week High"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/manipalhos\/manipal-health-enterpri-l-share-price-today\">MANIPAL HEALTH ENTERPRI L<\/a> traded at Rs 715.5, down 0.86% on the day, after touching a fresh 52-week high of Rs 738. The company\u2019s market capitalisation stood at Rs 93,043.21 crore.<\/p>\n<p style=\"margin-top:0!important;\">MANIPAL HEALTH ENTERPRI L Share Price traded at Rs 715.5 on 18 August 2026, down Rs 6.2 or 0.86% versus the previous close of Rs 721.7, but the stock still entered the day\u2019s Market News after touching a fresh 52-week high of Rs 738. With a market capitalisation of Rs 93,043.21 crore, the move matters because it shows the stock reached a new one-year high even though it later cooled from the session peak.<\/p>\n<p>For investors tracking MANIPAL HEALTH ENTERPRI L Share Price Today, the verified data confirms a clear price event: the stock opened at Rs 724.25, moved up to Rs 738, slipped to a low of Rs 713.65, and was trading close to that lower band at the captured price. Turnover stood at Rs 4.94 crore with volume of 68,985 shares, indicating measurable participation in the session.<\/p>\n<p>Why is the stock trending in Stocks in News screens? The supplied data establishes the 52-week high itself, the intraday range, the current valuation snapshot and the company\u2019s relative standing against Healthcare sector benchmarks. It does not establish a company-specific catalyst. For readers following MANIPAL HEALTH ENTERPRI L Stock News, that makes this a data-led price action story rather than a catalyst-driven one. In this Univest analysis, the next variables to monitor are whether the stock sustains attention near its yearly high and how its valuation and profitability metrics compare with peers and the broader Healthcare pack.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"MANIPAL_HEALTH_ENTERPRI_L_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>MANIPAL HEALTH ENTERPRI L Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 715.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 721.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Change<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -6.2 (-0.86%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 724.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Fresh 52-Week High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 738<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 713.65<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">68,985<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4.94 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 93,043.21 crore<\/td>\n<\/tr>\n<\/table>\n<p>MANIPAL HEALTH ENTERPRI L (MANIPALHOS) traded at Rs 715.5. versus the previous close of Rs 721.7, a fall of 0.86%. The stock opened at Rs 724.25, reached Rs 738, touched Rs 713.65. Reported volume was 68,985.<\/p>\n<p>MANIPAL HEALTH ENTERPRI L Share Price Today shows a session defined by an intraday breakout to a fresh 52-week peak of Rs 738, followed by a pullback to Rs 715.5. The stock reached a new one-year high during trade, but the last quoted level was below both the day\u2019s open and the previous close.<\/p>\n<p>Looking at the day in sequence, MANIPAL HEALTH ENTERPRI L Share Price opened at Rs 724.25 against a previous close of Rs 721.7, suggesting a firmer start. It then climbed to Rs 738, which now stands as both the day high and the fresh 52-week high. From there, the stock retreated and touched a day low of Rs 713.65 before trading at Rs 715.5 at the captured time.<\/p>\n<p>That means the stock was down Rs 6.2 on the day, or 0.86%, despite printing a new yearly high earlier in the session. This kind of setup often attracts attention in Share Market Today and Stock Market Today screens because it shows that buyers were strong enough to push the stock into a new 52 Week High zone, even if intraday profit-booking later emerged. For MANIPAL HEALTH ENTERPRI L Share News followers, the key verified takeaway is simple: a new 52-week peak was recorded, but the close-to-live price was below the peak.<\/p>\n<p>Trading volume stood at 68,985 shares and turnover was Rs 4.94 crore. That gives the move transactional relevance rather than making it a nominal tick higher on light value. In Univest\u2019s view, the price action is notable because the stock created a fresh high in the Indian Stock Market while still ending the observed window in the red, a combination that keeps attention on both momentum and valuation context.<\/p>\n<p>That naturally leads to the next question for MANIPAL HEALTH ENTERPRI L Share Price Live trackers: does the broader financial profile justify continued investor attention at these levels?<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"MANIPAL_HEALTH_ENTERPRI_L_MANIPALHOS_Fundamental_Analysis\"><\/span><strong>MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 93,043.21 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">170.32x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.42x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-2.89%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-0.26%<\/td>\n<\/tr>\n<\/table>\n<p>MANIPAL HEALTH ENTERPRI L was valued at a P\/E ratio of 170.32x, a P\/B ratio of 0.42x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.<\/p>\n<p>Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same sector<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">170.32x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">49.19x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 1,598.54x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.42x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.9x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-2.89%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.92%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-0.26%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.29%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 93,043.21 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 136.28 crore<\/td>\n<\/tr>\n<\/table>\n<p>MANIPAL HEALTH ENTERPRI L (MANIPALHOS) is classified under sector: Healthcare.<\/p>\n<p>MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a P\/E ratio of 170.32x, which is above the benchmark median of 21x, a difference of +711.05%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a ROE of -2.89%, which is below the benchmark median of 10.92%, a difference of -126.47%. MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dcal\/dishman-carbogen-amcis-ltd-share-price-today\"><strong>Dishman Carbogen Amcis Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DCAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,985.15<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">170.32<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0.42<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.26<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\"><strong>Beta Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BETA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,827.67<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">65.02<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.29<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.17<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/indswftlab\/ind-swift-laboratories-ltd-share-price-today\"><strong>Ind-Swift Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">INDSWFTLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,645.37<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">47.53<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.82<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.78<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.31<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dragarwq\/dr-agarwals-eye-hospital-ltd-share-price-today\"><strong>Dr Agarwals Eye Hospital Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DRAGARWQ<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,562.17<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.62<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.92<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/fredun\/fredun-pharmaceuticals-ltd-share-price-today\"><strong>Fredun Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">FREDUN<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,559.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">54.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.42<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.15<\/td>\n<\/tr>\n<\/table>\n<p>MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a P\/E ratio of 170.32x compared with the displayed peer median of 54.85x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of -0.78% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 13.15%, providing a capital-efficiency comparison. MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a market capitalisation of Rs 93,043.21 crore. Among the 5 peers shown, 0 have a larger market capitalisation.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_MANIPAL_HEALTH_ENTERPRI_L\"><\/span><strong>Why Investors Are Watching MANIPAL HEALTH ENTERPRI L<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The stock is drawing attention because the verified data combines a fresh 52-week high event with a distinctive valuation and sector position. For investors reviewing MANIPAL HEALTH ENTERPRI L Latest News, these are the main facts keeping the stock on the radar.<\/p>\n<ul>\n<li><strong>Fresh price event:<\/strong> the stock hit a new 52-week high of Rs 738 during the session.<\/li>\n<li><strong>Current trading level:<\/strong> MANIPAL HEALTH ENTERPRI L Share Price Today was Rs 715.5, down 0.86% from the previous close of Rs 721.7.<\/li>\n<li><strong>Intraday range:<\/strong> the stock opened at Rs 724.25, traded between Rs 713.65 and Rs 738, and showed active Price Action.<\/li>\n<li><strong>Participation:<\/strong> volume stood at 68,985 shares with turnover of Rs 4.94 crore.<\/li>\n<li><strong>Valuation context:<\/strong> P\/E of 170.32 is above the sector median of 21 and average of 49.19, while P\/B of 0.42 is below the sector median of 1.9.<\/li>\n<li><strong>Profitability context:<\/strong> ROE of -2.89 and ROCE of -0.26 are below the Healthcare benchmark medians of 10.92 and 13.29.<\/li>\n<li><strong>Scale:<\/strong> market capitalisation of Rs 93,043.21 crore is far above the benchmark median and average in the supplied sector universe.<\/li>\n<\/ul>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_MANIPAL_HEALTH_ENTERPRI_L\"><\/span><strong>About MANIPAL HEALTH ENTERPRI L<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>MANIPAL HEALTH ENTERPRI L is identified in the supplied data as a Healthcare sector company. Beyond that sector classification and the stock symbol MANIPALHOS, the verified dataset for this article is focused primarily on market activity, valuation and benchmark comparisons rather than a detailed operating profile.<\/p>\n<p>For investors reading MANIPAL HEALTH ENTERPRI L Company News and MANIPAL HEALTH ENTERPRI L Stock News, the most reliable contextual takeaway from the supplied information is that the company is being tracked within the Healthcare universe and is large in market-cap terms relative to the benchmark companies included in the same-sector comparison. The stock is also being evaluated against both pharmaceutical and hospital-related peers in the broader Healthcare basket, including Dishman Carbogen Amcis, Beta Drugs, Ind-Swift Laboratories, Dr Agarwals Eye Hospital and Fredun Pharmaceuticals.<\/p>\n<p>That means current attention around MANIPAL HEALTH ENTERPRI L Share Price is being driven less by business-description detail in the dataset and more by a combination of fresh 52 Week High Stocks screening, valuation multiples, relative profitability and sector positioning. Univest is therefore treating this as a market-led stock analysis event anchored in verified price and fundamental data.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_MANIPAL_HEALTH_ENTERPRI_L_Share_Price_on_Univest\"><\/span><strong>Track MANIPAL HEALTH ENTERPRI L Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/manipalhos\/manipal-health-enterpri-l-share-price-today\">MANIPAL HEALTH ENTERPRI L (MANIPALHOS) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Readers following MANIPAL HEALTH ENTERPRI L Share Price can use Univest to track live Share Price updates, 52-week levels, market capitalisation, valuation ratios and benchmark comparisons in one place. That is especially useful on days when a stock enters Stocks in News screens after touching a fresh one-year high.<\/p>\n<p>On Univest, users can monitor MANIPAL HEALTH ENTERPRI L Share Price Today alongside intraday moves, previous close references, turnover, volume, peer valuation metrics and sector context. For investors who prefer structured market insights over headline-only Stock Updates, that allows a cleaner read of how a fresh 52-week high fits into the broader stock analysis picture. Univest also helps users keep MANIPAL HEALTH ENTERPRI L Share Price Live on their watchlist without turning a factual market event into a recommendation.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_MANIPAL_HEALTH_ENTERPRI_L_Share_Price_Today\"><\/span><strong>What is MANIPAL HEALTH ENTERPRI L Share Price Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> MANIPAL HEALTH ENTERPRI L Share Price Today was Rs 715.5 at the captured time on 18 August 2026. The stock was down Rs 6.2 or 0.86% from the previous close of Rs 721.7.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_MANIPAL_HEALTH_ENTERPRI_L_hit_a_52-week_high_today\"><\/span><strong>Did MANIPAL HEALTH ENTERPRI L hit a 52-week high today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes, MANIPAL HEALTH ENTERPRI L hit a fresh 52-week high of Rs 738 during the session. Even after touching that one-year high, the stock later traded lower at Rs 715.5 in the observed update.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_MANIPAL_HEALTH_ENTERPRI_L_Stock_News_trending_today\"><\/span><strong>Why is MANIPAL HEALTH ENTERPRI L Stock News trending today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The verified data shows the stock is trending because it touched a fresh 52-week peak of Rs 738. The dataset confirms the price event, turnover of Rs 4.94 crore and volume of 68,985 shares.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_did_MANIPAL_HEALTH_ENTERPRI_L_move_today\"><\/span><strong>How much did MANIPAL HEALTH ENTERPRI L move today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock was down Rs 6.2 on the day, a decline of 0.86% versus the previous close of Rs 721.7. Despite that negative day change, it still recorded a fresh 52-week high intraday.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_intraday_range_for_MANIPAL_HEALTH_ENTERPRI_L\"><\/span><strong>What was the intraday range for MANIPAL HEALTH ENTERPRI L?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> MANIPAL HEALTH ENTERPRI L traded between a day low of Rs 713.65 and a day high of Rs 738. The stock opened at Rs 724.25, showing a wide intraday range around the fresh yearly high.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_MANIPAL_HEALTH_ENTERPRI_L\"><\/span><strong>What is the market capitalisation of MANIPAL HEALTH ENTERPRI L?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> MANIPAL HEALTH ENTERPRI L had a market capitalisation of Rs 93,043.21 crore in the supplied data. That is far above the Healthcare benchmark median of Rs 136.28 crore and average of Rs 468.36 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_is_MANIPAL_HEALTH_ENTERPRI_L_valued_on_PE_and_PB\"><\/span><strong>How is MANIPAL HEALTH ENTERPRI L valued on P\/E and P\/B?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock\u2019s P\/E ratio was 170.32 and its P\/B ratio was 0.42. Compared with the Healthcare benchmark, the P\/E is above the median 21 and average 49.19, while P\/B is below median 1.9.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_the_ROE_and_ROCE_figures_show_for_MANIPAL_HEALTH_ENTERPRI_L\"><\/span><strong>What do the ROE and ROCE figures show for MANIPAL HEALTH ENTERPRI L?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> ROE was -2.89 and ROCE was -0.26 in the supplied dataset. Both figures are below the Healthcare benchmark medians of 10.92 for ROE and 13.29 for ROCE, showing weaker reported returns.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_MANIPAL_HEALTH_ENTERPRI_L_compare_with_peers\"><\/span><strong>How does MANIPAL HEALTH ENTERPRI L compare with peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> MANIPAL HEALTH ENTERPRI L has a much larger market capitalisation than the supplied peers, but its P\/E of 170.32 is higher than Beta Drugs, Ind-Swift Laboratories, Dr Agarwals Eye Hospital and Fredun Pharmaceuticals.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_next_in_MANIPAL_HEALTH_ENTERPRI_L_Share_Price\"><\/span><strong>What should investors monitor next in MANIPAL HEALTH ENTERPRI L Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors can monitor whether the stock continues to hold market attention after hitting Rs 738, while also tracking valuation ratios, return metrics, volume participation and its position against Healthcare sector benchmarks.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>MANIPAL HEALTH ENTERPRI L Share Price hits a new 52-week high at Rs 715.5. marking a -0.86% rise today. Market cap stands at Rs 93,043.21 crore.<\/p>\n","protected":false},"author":29,"featured_media":210371,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-210372","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["210371"],"rank_math_title":["MANIPAL HEALTH ENTERPRI L Share Price: 52-Week High Analysis"],"rank_math_description":["MANIPAL HEALTH ENTERPRI L Share Price hit a fresh 52-week high of Rs 738. Read price action, valuation, peer comparison and sector analysis."],"rank_math_focus_keyword":["MANIPAL HEALTH ENTERPRI L Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/MANIPAL_HEALTH_ENTERPRI_L_MANIPALHOS_Share_Price_Hits_Fresh_52_Week_High_bullish-5.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/210372","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=210372"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/210372\/revisions"}],"predecessor-version":[{"id":210373,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/210372\/revisions\/210373"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/210371"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=210372"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=210372"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=210372"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}